↑Wang K, Grivennikov SI, Karin M (April 2013). "Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases". Annals of the Rheumatic Diseases. 72 Suppl 2: ii100–3. doi:10.1136/annrheumdis-2012-202201. PMID23253923. We have shown interleukin (IL)-6 to be an important tumour promoter in early colitis-associated cancer (CAC).
↑Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, Grivennikov S, Wynshaw-Boris A, Scadeng M, Olefsky JM, Karin M (November 2007). "JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity". Cell Metabolism. 6 (5): 386–97. doi:10.1016/j.cmet.2007.09.011. PMID17983584. Activation of JNKs (mainly JNK1) in insulin target cells results in phosphorylation of insulin receptor substrates (IRSs) at serine and threonine residues that inhibit insulin signaling.
↑
Bu Z, Callaway DJ (2011). "Proteins move! Protein dynamics and long-range allostery in cell signaling". Protein Structure and Diseases. Advances in Protein Chemistry and Structural Biology. Vol. 83. pp. 163–221. doi:10.1016/B978-0-12-381262-9.00005-7. ISBN978-0-12-381262-9. PMID21570668.